BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3779712)

  • 1. Effect of dose escalation of a monoclonal anti-CEA IgG on tumour localisation and tissue distribution in nude mice xenografted with human colon carcinoma.
    Rogers GT; Pedley RB; Boden J; Harwood PJ; Bagshawe KD
    Cancer Immunol Immunother; 1986; 23(2):107-12. PubMed ID: 3779712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of circulatory clearance of tumour-localising IgG and F(ab')2 for potential therapy studied in a CEA-producing xenograft model.
    Harwood PJ; Pedley RB; Boden J; Rogers GT
    Tumour Biol; 1987; 8(1):19-25. PubMed ID: 3602844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of monoclonal antibody distribution and prolonged tumour localisation in nude mice bearing a human CEA-producing colon carcinoma xenograft.
    Rogers GT; Harwood PJ; Pedley RB; Boden J; Rawlins G; Bagshawe KD
    Tumour Biol; 1986; 6(5):453-63. PubMed ID: 3704478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.
    Vogel CA; Bischof-Delaloye A; Mach JP; Pèlegrin A; Hardman N; Delaloye B; Buchegger F
    Br J Cancer; 1993 Oct; 68(4):684-90. PubMed ID: 8398694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative tumour localization of antibody fragments and intact IgG in nude mice bearing a CEA-producing human colon tumour xenograft.
    Harwood PJ; Boden J; Pedley RB; Rawlins G; Rogers GT; Bagshawe KD
    Eur J Cancer Clin Oncol; 1985 Dec; 21(12):1515-22. PubMed ID: 3830730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake of a monoclonal antibody against CEA (Tumak 431/31) in a human colon tumor (Co-112) xenografted in the nude mouse. Dependence on tumor size and injected dose.
    Duewell S; Horst W; Westera G
    Cancer Immunol Immunother; 1986; 23(2):101-6. PubMed ID: 3779711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunotherapy of human colon carcinoma by 131I-labelled monoclonal anti-CEA antibodies in a nude mouse model.
    Buchegger F; Vacca A; Carrel S; Schreyer M; Mach JP
    Int J Cancer; 1988 Jan; 41(1):127-34. PubMed ID: 3335416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
    Pedley RB; Boden JA; Boden R; Dale R; Begent RH
    Br J Cancer; 1993 Jul; 68(1):69-73. PubMed ID: 8318423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
    Pedley RB; Boden JA; Boden RW; Green A; Boxer GM; Bagshawe KD
    Br J Cancer; 1989 Oct; 60(4):549-54. PubMed ID: 2803924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-specific-activity 111In-labeled anticarcinoembryonic antigen monoclonal antibody: biodistribution and imaging in nude mice bearing human colon cancer xenografts.
    Jakowatz JG; Beatty BG; Vlahos WG; Porudominsky D; Philben VJ; Williams LE; Paxton RJ; Shively JE; Beatty JD
    Cancer Res; 1985 Nov; 45(11 Pt 2):5700-6. PubMed ID: 4053043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged localisation of a monoclonal antibody against CEA in a human colon tumour xenograft.
    Harwood PJ; Pedley RB; Boden J; Rawlins G; Pentycross CR; Rogers GT; Bagshawe KD
    Br J Cancer; 1985 Nov; 52(5):797-9. PubMed ID: 2998427
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo studies on the uptake of radiolabelled antibodies by colorectal and gastric carcinoma xenografts.
    Macdonald F; Crowson MC; Allum WH; Life P; Fielding JW
    Cancer Immunol Immunother; 1986; 23(2):119-24. PubMed ID: 3779713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice.
    Buchegger F; Haskell CM; Schreyer M; Scazziga BR; Randin S; Carrel S; Mach JP
    J Exp Med; 1983 Aug; 158(2):413-27. PubMed ID: 6886623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orthotopic xenografts of human melanoma and colonic and ovarian carcinoma in sheep to evaluate radioimmunotherapy.
    Turner JH; Rose AH; Glancy RJ; Penhale WJ
    Br J Cancer; 1998 Aug; 78(4):486-94. PubMed ID: 9716032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between tumour size and uptake of radiolabelled anti-CEA in a colon tumour xenograft.
    Pedley RB; Boden J; Keep PA; Harwood PJ; Green AJ; Rogers GT
    Eur J Nucl Med; 1987; 13(4):197-202. PubMed ID: 3040415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.
    Buchegger F; Pfister C; Fournier K; Prevel F; Schreyer M; Carrel S; Mach JP
    J Clin Invest; 1989 May; 83(5):1449-56. PubMed ID: 2708519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: a model for radioimmunotherapy.
    Vogel CA; Galmiche MC; Westermann P; Sun LQ; Pèlegrin A; Folli S; Bischof Delaloye A; Slosman DO; Mach JP; Buchegger F
    Int J Cancer; 1996 Jul; 67(2):294-302. PubMed ID: 8760602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
    Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
    Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft model.
    Pedley RB; Begent RH; Boden JA; Boden R; Adam T; Bagshawe KD
    Int J Cancer; 1991 Feb; 47(4):597-602. PubMed ID: 1995488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for enhanced tumour localisation by poly(ethylene glycol) modification of anti-CEA antibody.
    Pedley RB; Boden JA; Boden R; Begent RH; Turner A; Haines AM; King DJ
    Br J Cancer; 1994 Dec; 70(6):1126-30. PubMed ID: 7981064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.